Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years

Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses

(2022) Jinhua Bao et al.   JAMA Ophthalmology

Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS)

(2022) Joe Rappon et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Compounding of Low-Concentration Atropine for Myopia Control

(2022) Kathryn Richdale et al.   Eye & Contact Lens-Science and Clinical Practice

Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial

(2022) Shiao Yu et al.   BMC Ophthalmology

Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis

(2021) Ning Yang et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study

(2021) Osamu Hieda et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Atropine for treatment of childhood myopia in India (I-ATOM): multicentric randomized trial

(2021) Rohit Saxena et al.   OPHTHALMOLOGY

The Risks and Benefits of Myopia Control

(2021) Mark A. Bullimore et al.   OPHTHALMOLOGY

Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series

(2021) Nir Erdinest et al.   Case Reports in Ophthalmology

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial

(2021) Ying Yuan et al.   Trials

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial

(2021) Can Cui et al.   Scientific Reports

Biological Mechanisms of Atropine Control of Myopia

(2020) Aradhana Upadhyay et al.   Eye & Contact Lens-Science and Clinical Practice

Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children

(2020) Shifei Wei et al.   JAMA Ophthalmology

Efficacy in myopia control

(2020) Noel A. Brennan et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Myopia Control

(2019) Mark A. Bullimore et al.   OPTOMETRY AND VISION SCIENCE

A 3-Year Randomized Clinical Trial of MiSight Lenses for Myopia Control

(2019) Paul Chamberlain et al.   OPTOMETRY AND VISION SCIENCE

Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling

(2018) Timothy R Fricke et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Update in myopia and treatment strategy of atropine use in myopia control

(2018) Pei-Chang Wu et al.   EYE

Low-Concentration Atropine for Myopia Progression (LAMP) Study

(2018) Jason C. Yam et al.   OPHTHALMOLOGY

The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia

(2018) Lei Wan et al.   Journal of Clinical Medicine

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2

(2016) Audrey Chia et al.   OPHTHALMOLOGY

Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050

(2016) Brien A. Holden et al.   OPHTHALMOLOGY

Unknown

(2016)   ACTA OPHTHALMOLOGICA

Compounding Pharmacy Conundrum

(2013) Roy Guharoy et al.   CHEST

The Risk of Microbial Keratitis With Overnight Corneal Reshaping Lenses

(2013) Mark A. Bullimore et al.   OPTOMETRY AND VISION SCIENCE

Potential Risks of Pharmacy Compounding

(2013) Jennifer Gudeman et al.   Drugs in research & development

Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2)

(2011) Audrey Chia et al.   OPHTHALMOLOGY

Myopia Progression Rates in Urban Children Wearing Single-Vision Spectacles

(2011) Leslie Donovan et al.   OPTOMETRY AND VISION SCIENCE